News
-
31 Jul, 2023
Spago Nanomedical interim report January-June 2023
-
31 Jul, 2023
Spago Nanomedical delårsrapport januari-juni 2023
-
28 Jun, 2023
Spago Nanomedical uppdaterar om den kliniska fas IIa-studien SPAGOPIX-02
-
28 Jun, 2023
Spago Nanomedical updates on the clinical phase IIa study SPAGOPIX-02
-
13 Jun, 2023
Spago Nanomedical stärker Tumorad® genom nytt vetenskapligt råd
-
13 Jun, 2023
Spago Nanomedical strengthens Tumorad® by establishment of Scientific Advisory Board
-
23 May, 2023
Spago Nanomedical has submitted application to start Tumorad® clinical phase I/IIa study
-
23 May, 2023
Spago Nanomedical har lämnat in ansökan om att starta klinisk fas I/IIa-studie med Tumorad®
-
10 May, 2023
Kommuniké från årsstämma 2023 i Spago Nanomedical AB
-
10 May, 2023
Bulletin from the 2023 Annual General Meeting of Spago Nanomedical AB